University of Melbourne

The University of Melbourne (UoM) NIF Node empowers groundbreaking research in biomedical imaging, providing access to world-class advanced human and frontier imaging technologies, and cutting-edge radiopharmaceutical facilities across two clinical sites and the UoM main Parkville campus.

The UoM node supports radiochemistry facilities at Austin Health (AH) and the Peter MacCallum Cancer Centre (PMCC), two Departments with internationally recognised reputation in basic, translational and clinical research into PET imaging and theranostics in neuroscience, oncology and metabolic diseases. AH and PMCC have established radiochemistry, cyclotron, preclinical and clinical infrastructure for developing, validating and translating novel radiopharmaceuticals into the clinic.

At the PMCC, the Australian Cancer Research Foundation’s Centre for Advanced Imaging-Guided Cancer Therapeutics spearheaded the 2025 installation of a world-first next-generation GE Healthcare OMNI 128 Total Body PET/CT, representing a major advance in human scanning, enabling accelerated development of cancer imaging and therapeutics to support prevention, early detection and advanced cancer research programs. The platform enables ultra-fast total body human molecular scanning allowing new applications including dynamic pharmacodynamic imaging for validation of novel tumour-targeted radiotracers, immune system imaging, cell tracking and paediatric applications.